Acrizanib as a Novel Therapeutic Agent for Fundus Neovascularization via Inhibitory Phosphorylation of VEGFR2.

Authors:
Tang X; Cui K; Wu P; Hu A; Fan M and 6 more

Journal:
Transl Vis Sci Technol

Publication Year: 2024

DOI:
10.1167/tvst.13.1.1

PMCID:
PMC10768700

PMID:
38165719

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Transl Vis Sci Technol

Abbreviation: Transl Vis Sci Technol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Biomedical Engineering

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A Bayesian Hierarchical Spatial Longitudinal Model Improves Estimation of Local Macular Rates of Ch…
Su E; Mohammadzadeh V; Mohammadi M and 6 more (2024) - Transparency Score: 3/6
Acanthamoeba Keratitis in China: Genotypic and Clinical Correlations.
Pang J; Wei Z; Wang L and 14 more (2024) - Transparency Score: 3/6
A Catalog of Patent Applications Published in 2023 Related to Ophthalmology and Vision Science.
Stern G; Mallett JJ. (2024) - Transparency Score: 1/6
Aprepitant Restores Corneal Sensitivity and Reduces Pain in DED.
Bonelli F; Campestre F; Lasagni Vitar RM and 3 more (2024) - Transparency Score: 3/6
Are Macula or Optic Nerve Head Structures Better at Diagnosing Glaucoma? An Answer Using Artificial…
Chiang CYN; Braeu FA; Chuangsuwanich T and 6 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosure: X. Tang, None; K. Cui, None; P. Wu, None; A. Hu, None; M. Fan, None; X. Lu, None; F. Yang, None; J. Lin, None; S. Yu, None; Y. Xu, None; X. Liang, None"

Evidence found in paper:

"Supported by the National Natural Science Foundation of China (82271099, 81970807), the Research Grant from Guangzhou Municipal Science and Technology Bureau in China (202201020507), and the Natural Science Foundation of Guangdong Province in China (2022A1515010355)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025